Leukemia, lymphoma, and myeloma are highly treatable, and often curable, forms of blood cancer. A quick, precise diagnosis is the most important first step in tailoring your treatment plan.
At the AHN Cancer Institute, we use sophisticated technology to diagnose different types of blood cancer. You can expect the diagnostic process to be:
Our cancer specialists have the expertise to get you the right diagnosis so you can begin treatment. Often, we diagnose blood cancers and disorders through a complete blood count (CBC), which might show elevated or decreased blood cell counts.
Initial tests for diagnosing leukemia, lymphoma, and myeloma might include:
Complete blood count: We draw a small blood sample. Then, our laboratories quickly analyze your results for abnormalities.
Bone marrow biopsy: During this procedure, we take a small amount of bone marrow fluid or tissue, usually from the hip, to analyze cells for signs of cancer.
Cytogenetic testing: Our chromosomes carry our genetic information (DNA). Cytogenetic testing is a sophisticated procedure that analyzes chromosomal changes that may indicate cancer. Understanding cellular makeup helps us pinpoint an exact diagnosis and plan a better treatment.
Once you have been diagnosed, a team of experts reviews your results and develops a personalized treatment plan. Treatment options include chemotherapy, immunotherapy, radiation therapy, and cellular therapy. Get more information on treatment for leukemia, lymphoma, and myeloma.
Call the AHN Cancer Help Line anytime at (412) NURSE-4-U (412) 687-7348 to schedule a cancer-related appointment or to just talk with our nurses about diagnoses, treatments, and side effects.
